SC-112c

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSC-112c
Drug Alias NameSC-112c
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDyslexia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesScotia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScotia
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityDyslexia

Other Information

ATC CodeN/A
Related LinksN/A